USA - NYSE:CXM - US85208T1079 - Common Stock
ChartMill assigns a Buy % Consensus number of 69% to CXM. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-30 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-09-09 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-09-04 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-09-04 | Barclays | Maintains | Underweight -> Underweight |
| 2025-06-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-05 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-06-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-05 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-06-05 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-06-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-22 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-04-16 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-14 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-03-13 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-13 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-03-13 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-03-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-07 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-07 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-12-16 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-11 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-12-05 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-12-05 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-12-05 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-12-05 | Rosenblatt | Maintains | Buy -> Buy |
| 2024-12-05 | Stifel | Maintains | Hold -> Hold |
| 2024-12-05 | Barclays | Maintains | Underweight -> Underweight |
| 2024-11-12 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2024-10-07 | Barclays | Downgrade | Overweight -> Underweight |
| 2024-09-05 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
14 analysts have analysed CXM and the average price target is 10.65 USD. This implies a price increase of 36.76% is expected in the next year compared to the current price of 7.79.
The consensus rating for SPRINKLR INC-A (CXM) is 68.5714 / 100 . This indicates that analysts generally have a neutral outlook on the stock.